Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Brain Research
|
May 14, 1993
The role of dopamine in the maintenance and breakdown of D1/D2 synergism
G J LaHoste, J F Marshall
Synapse (New York, N.Y.)
|
September 1, 1992
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density
G J LaHoste, J F Marshall
Behavioural Brain Research
|
May 28, 1990
Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists
G J LaHoste, J F Marshall
Brain Research
|
November 20, 1989
Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action
G J LaHoste, J F Marshall
Neuroscience
|
December 15, 2005
Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity
L M Harrison, G J LaHoste
Neuroscience Letters
|
September 26, 1994
Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression
G J LaHoste, J F Marshall
Neuroscience
|
January 1, 1991
Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis
G J LaHoste, J F Marshall
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 1993
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
G J LaHoste, J Yu, J F Marshall
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 31, 2000
Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials
G J LaHoste, B L Henry, J F Marshall
Brain Research
|
December 31, 1993
Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres
J F Marshall, B N Cole, G J LaHoste
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Brain Research
|
May 14, 1993
The role of dopamine in the maintenance and breakdown of D1/D2 synergism
G J LaHoste, J F Marshall
Synapse (New York, N.Y.)
|
September 1, 1992
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density
G J LaHoste, J F Marshall
Behavioural Brain Research
|
May 28, 1990
Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists
G J LaHoste, J F Marshall
Brain Research
|
November 20, 1989
Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action
G J LaHoste, J F Marshall
Neuroscience
|
December 15, 2005
Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity
L M Harrison, G J LaHoste
Neuroscience Letters
|
September 26, 1994
Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression
G J LaHoste, J F Marshall
Neuroscience
|
January 1, 1991
Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis
G J LaHoste, J F Marshall
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 1993
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity
G J LaHoste, J Yu, J F Marshall
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 31, 2000
Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials
G J LaHoste, B L Henry, J F Marshall
Brain Research
|
December 31, 1993
Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres
J F Marshall, B N Cole, G J LaHoste
Page
of 3